» Articles » PMID: 30430715

Recovery of Myocardial Perfusion After Percutaneous Coronary Intervention of Chronic Total Occlusions is Comparable to Hemodynamically Significant Non-occlusive Lesions

Abstract

Background: The benefits of chronic coronary total occlusion (CTO) percutaneous coronary intervention (PCI) are being questioned. The aim of this study was to assess the effects of CTO PCI on absolute myocardial perfusion, as compared with PCI of hemodynamically significant non-CTO lesions.

Methods: Consecutive patients with a preserved left ventricular ejection fraction (≥50%) and a CTO or non-CTO lesion, in whom [ O]H O positron emission tomography was performed prior and after successful PCI, were included. Change in quantitative (hyperemic) myocardial blood flow (MBF), coronary flow reserve (CFR) and perfusion defect size (in myocardial segments) were compared between CTOs and non-CTO lesions.

Results: In total 92 patients with a CTO and 31 patients with a non-CTO lesion were included. CTOs induced larger perfusion defect sizes (4.51 ± 1.69 vs. 3.23 ± 2.38 segments, P < 0.01) with lower hyperemic MBF (1.30 ± 0.37 vs. 1.58 ± 0.62 mL·min ·g , P < 0.01) and similarly impaired CFR (1.66 ± 0.75 vs. 1.89 ± 0.77, P = 0.17) compared with non-CTO lesions. After PCI both hyperemic MBF and CFR increased similarly between groups (P = 0.57 and 0.35) to normal ranges with higher hyperemic MBF values in non-CTO compared with CTO (2.89 ± 0.94 vs. 2.48 ± 0.73 mL·min ·g , P = 0.03). Perfusion defect sizes decreased similarly after CTO PCI and non-CTO PCI (P = 0.14), leading to small residual defect sizes in both groups (1.15 ± 1.44 vs. 0.61 ± 1.45 segments, P = 0.054).

Conclusions: Myocardial perfusion findings are slightly more hampered in patients with a CTO before and after PCI. Percutaneous revascularization of CTOs, however, improves absolute myocardial perfusion similarly to PCI of hemodynamically significant non-CTO lesions, leading to satisfying results.

Citing Articles

N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularization.

Gold D, Sandesara P, Jain V, Gold M, Vatsa N, Desai S Int J Cardiol. 2024; 409:132196.

PMID: 38782069 PMC: 11586920. DOI: 10.1016/j.ijcard.2024.132196.


Ten-Year Outcome of Recanalization or Medical Therapy for Concomitant Chronic Total Occlusion After Myocardial Infarction.

van Veelen A, Coerkamp C, Somsen Y, Ramunddal T, Ioanes D, Laanmets P J Am Heart Assoc. 2024; 13(10):e033556.

PMID: 38726918 PMC: 11179819. DOI: 10.1161/JAHA.123.033556.


Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.

Gold D, Sandesara P, Kindya B, Gold M, Jain V, Vatsa N Int J Cardiol. 2024; 407:132104.

PMID: 38677332 PMC: 11559591. DOI: 10.1016/j.ijcard.2024.132104.


Computed Tomography Angiography-Derived Scores for Prediction of Chronic Total Occlusion Percutaneous Coronary Intervention Using the Hybrid Algorithm.

Zysk A, Wolny R, Kruk M, Kwiecinski J, Debski A, Barbero U J Cardiovasc Dev Dis. 2024; 11(1).

PMID: 38248873 PMC: 10817054. DOI: 10.3390/jcdd11010003.


High Sensitivity Troponin Level and Benefits of Chronic Total Occlusion Revascularization.

Gold D, Sandesara P, Jain V, Gold M, Vatsa N, Desai S J Am Heart Assoc. 2023; 12(21):e031431.

PMID: 37929763 PMC: 10727412. DOI: 10.1161/JAHA.123.031431.


References
1.
Hicks K, Tcheng J, Bozkurt B, Chaitman B, Cutlip D, Farb A . 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop.... J Am Coll Cardiol. 2015; 66(4):403-69. DOI: 10.1016/j.jacc.2014.12.018. View

2.
Fefer P, Knudtson M, Cheema A, Galbraith P, Osherov A, Yalonetsky S . Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012; 59(11):991-7. DOI: 10.1016/j.jacc.2011.12.007. View

3.
Hachamovitch R, Hayes S, Friedman J, Cohen I, Berman D . Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003; 107(23):2900-7. DOI: 10.1161/01.CIR.0000072790.23090.41. View

4.
Galassi A, Werner G, Tomasello S, Azzarelli S, Capodanno D, Barrano G . Prognostic value of exercise myocardial scintigraphy in patients with coronary chronic total occlusions. J Interv Cardiol. 2010; 23(2):139-48. DOI: 10.1111/j.1540-8183.2010.00527.x. View

5.
Maeremans J, Walsh S, Knaapen P, Spratt J, Avran A, Hanratty C . The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe: The RECHARGE Registry. J Am Coll Cardiol. 2016; 68(18):1958-1970. DOI: 10.1016/j.jacc.2016.08.034. View